| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2928241 | Indian Heart Journal | 2012 | 7 Pages |
Abstract
This study confirms the limited exposure of the systemic circulation of the eluted drug with the use of the Supralimus-Core® Sirolimus-Eluting Coronary Stent System (Sahajanand Medical Technologies Pvt. Ltd., Surat, India). In this study, sirolimus concentration in systemic circulation is to be safe, well-tolerated and short-lived.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ashok S. Thakkar, Atul D. Abhyankar, Sameer I. Dani, Darshan N. Banker, Parvinder I. Singh, Sanjay A. Parmar, Anita A. Mehta,